ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $13,890,068,000 | +55.2% | 149,452 | -0.6% | 0.01% | +25.0% |
Q3 2021 | $8,950,961,000 | -15.0% | 150,310 | -2.7% | 0.00% | -20.0% |
Q2 2021 | $10,531,034,000 | -2.7% | 154,414 | -1.1% | 0.01% | 0.0% |
Q1 2021 | $10,828,655,000 | -64.5% | 156,055 | -60.7% | 0.01% | -64.3% |
Q4 2020 | $30,514,724,000 | +148.3% | 397,172 | +141.7% | 0.01% | +100.0% |
Q3 2020 | $12,290,615,000 | +23.8% | 164,335 | +4.2% | 0.01% | +16.7% |
Q2 2020 | $9,929,420,000 | +326.5% | 157,735 | +184.5% | 0.01% | +200.0% |
Q1 2020 | $2,328,354,000 | -7.1% | 55,437 | +0.4% | 0.00% | 0.0% |
Q4 2019 | $2,506,820,000 | +2.2% | 55,192 | +3.0% | 0.00% | 0.0% |
Q3 2019 | $2,453,134,000 | +3.2% | 53,597 | +32.3% | 0.00% | 0.0% |
Q2 2019 | $2,376,098,000 | +42.1% | 40,527 | +8.6% | 0.00% | +100.0% |
Q1 2019 | $1,672,427,000 | +20.1% | 37,306 | +4.3% | 0.00% | 0.0% |
Q4 2018 | $1,392,969,000 | -5.5% | 35,763 | +11.7% | 0.00% | 0.0% |
Q3 2018 | $1,473,607,000 | +5.6% | 32,021 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,396,115,000 | +75.9% | 32,021 | +59.3% | 0.00% | 0.0% |
Q1 2018 | $793,793,000 | +62.4% | 20,096 | +39.7% | 0.00% | – |
Q4 2017 | $488,693,000 | – | 14,386 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |